Clorox (NYSE:CLX) Stock Gets Downgrade from Zacks Research

Clorox (NYSE:CLX) was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued on Thursday, Zacks reports. Zacks Research also issued estimates for Clorox’s Q1 2027 earnings at $0.91 EPS, Q2 2027 earnings at $1.30 EPS, Q3 2027 earnings at $1.56 EPS, Q4 2027 earnings at $1.77 EPS and FY2027 earnings at $5.53 EPS.

Other equities research analysts have also recently issued reports about the company. Citigroup lowered their target price on Clorox from $97.00 to $90.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 14th. Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a research report on Tuesday, October 6th. UBS Group set a $91.00 price target on shares of Clorox in a research report on Thursday, October 15th. JPMorgan Chase & Co. decreased their price objective on shares of Clorox from $95.00 to $83.00 and set an “underweight” rating for the company in a report on Monday, October 19th. Finally, Morgan Stanley lowered their price objective on shares of Clorox from $97.00 to $87.00 and set an “equal weight” rating on the stock in a research report on Thursday, October 15th. Eleven investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus price target of $93.57.

Clorox Price Performance

Shares of NYSE:CLX opened at $88.01 on Thursday. The company has a current ratio of 0.66, a quick ratio of 0.38 and a debt-to-equity ratio of 15.80. The stock has a market cap of $10.64 billion, a PE ratio of 18.26, a price-to-earnings-growth ratio of 2.97 and a beta of 0.59. The stock’s fifty day simple moving average is $88.61 and its two-hundred day simple moving average is $100.01. Clorox has a 1-year low of $79.12 and a 1-year high of $128.90.

Clorox (NYSE:CLX) last announced its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.02. The firm had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.91 billion. Clorox had a return on equity of 522.23% and a net margin of 8.74%. The company’s revenue was down 2.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, analysts forecast that Clorox will post 5.66 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Kestra Private Wealth Services LLC grew its position in shares of Clorox by 1.8% during the 1st quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock valued at $617,000 after purchasing an additional 104 shares in the last quarter. Geneos Wealth Management Inc. increased its holdings in shares of Clorox by 9.3% in the first quarter. Geneos Wealth Management Inc. now owns 1,402 shares of the company’s stock worth $145,000 after purchasing an additional 119 shares during the period. Elevation Wealth Partners LLC raised its position in shares of Clorox by 32.3% in the third quarter. Elevation Wealth Partners LLC now owns 565 shares of the company’s stock worth $46,000 after buying an additional 138 shares in the last quarter. Root Financial Partners LLC raised its position in shares of Clorox by 83.8% in the first quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after buying an additional 145 shares in the last quarter. Finally, Eastern Bank grew its position in Clorox by 3.1% during the third quarter. Eastern Bank now owns 5,052 shares of the company’s stock worth $409,000 after buying an additional 150 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: New CEO appointed: Clorox named Fabian Garcia, a veteran consumer-products executive from Unilever, as CEO and chair effective January 5, 2027. His experience could help strengthen brand execution and support a turnaround after a comprehensive search. Matthew Shattock will resume his role as independent chair, while Linda Rendle is stepping down for health reasons. Clorox Appoints Fabian Garcia as CEO
• Positive Sentiment: Potential earnings support: Analysts expect fiscal first-quarter 2027 results to benefit from product innovation, brand investments and the contribution from GOJO, the hand-care business acquired by Clorox. A stronger-than-expected report could provide a near-term catalyst. Clorox’s Q1 Earnings Coming Up: Key Insights for Investors
• Neutral Sentiment: Valuation is being debated: Recent commentary suggests CLX may be fairly valued based on expected earnings, while the incoming CEO could make the stock appear inexpensive if he improves growth and profitability. Investors are likely to focus on guidance and the pace of recovery rather than valuation alone. Clorox Stock Looks About Right Based on Earnings
• Negative Sentiment: Profitability and dividend risks remain: Higher costs, cautious consumer spending and potential pressure on margins may limit the benefit from innovation and GOJO. Analysts also view the dividend as facing a more difficult test, making cash flow and management’s outlook key issues in the earnings release. Clorox: An Easy Quarter Ahead, But a Harder Test for the Dividend

About Clorox

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.